Page last updated: 2024-10-31

midazolam and Postpartum Hemorrhage

midazolam has been researched along with Postpartum Hemorrhage in 2 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Postpartum Hemorrhage: Excess blood loss from uterine bleeding associated with OBSTETRIC LABOR or CHILDBIRTH. It is defined as blood loss greater than 500 ml or of the amount that adversely affects the maternal physiology, such as BLOOD PRESSURE and HEMATOCRIT. Postpartum hemorrhage is divided into two categories, immediate (within first 24 hours after birth) or delayed (after 24 hours postpartum).

Research Excerpts

ExcerptRelevanceReference
"To compare the efficacy of dexmedetomidine and midazolam in the prevention of postoperative nausea and vomiting (PONV) caused by hemabate in postpartum hemorrhage during cesarean delivery."9.34A Comparison of Dexmedetomidine and Midazolam for the Prevention of Postoperative Nausea and Vomiting Caused by Hemabate in Cesarean Delivery: A Randomized Controlled Trial. ( Hu, B; Li, X; Shi, J; Tan, L; Zhou, H; Zou, X, 2020)
"To compare the efficacy of dexmedetomidine and midazolam in the prevention of postoperative nausea and vomiting (PONV) caused by hemabate in postpartum hemorrhage during cesarean delivery."5.34A Comparison of Dexmedetomidine and Midazolam for the Prevention of Postoperative Nausea and Vomiting Caused by Hemabate in Cesarean Delivery: A Randomized Controlled Trial. ( Hu, B; Li, X; Shi, J; Tan, L; Zhou, H; Zou, X, 2020)
"An 18-year-old patient had postpartum hemorrhage after a normal delivery."1.46Posterior reversible encephalopathy syndrome after postpartum hemorrhage and uterine artery embolization: A case report. ( Jin, Z; Liu, W; Shen, L; Shi, F; Shi, L; Shi, Y; Wu, D; Yang, X, 2017)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Hu, B1
Zhou, H1
Zou, X1
Shi, J1
Li, X1
Tan, L1
Shi, F1
Shen, L1
Shi, Y1
Shi, L1
Yang, X1
Jin, Z1
Liu, W1
Wu, D1

Trials

1 trial available for midazolam and Postpartum Hemorrhage

ArticleYear
A Comparison of Dexmedetomidine and Midazolam for the Prevention of Postoperative Nausea and Vomiting Caused by Hemabate in Cesarean Delivery: A Randomized Controlled Trial.
    Drug design, development and therapy, 2020, Volume: 14

    Topics: Adult; Cesarean Section; Dexmedetomidine; Female; Humans; Injections, Intravenous; Midazolam; Postop

2020

Other Studies

1 other study available for midazolam and Postpartum Hemorrhage

ArticleYear
Posterior reversible encephalopathy syndrome after postpartum hemorrhage and uterine artery embolization: A case report.
    Medicine, 2017, Volume: 96, Issue:49

    Topics: Adolescent; Anticonvulsants; Diazepam; Female; Humans; Hypnotics and Sedatives; Magnetic Resonance I

2017